Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Ponderus Invest is a Swedish family-owned investment company and family office owned by the Edwall family. The firm focuses on long-term capital management and value-creating investments rather than developing therapeutics, medical products, or healthcare services. Publicly available information indicates that it combines stable financial assets with selective investments in growth companies and has recently been notable as the majority owner and takeover bidder for Ortivus, a listed healthcare IT and medtech company. Ponderus Invest itself does not appear to operate as a biotech, pharma, healthcare, CRO, or CDMO company and does not disclose a drug pipeline or R&D platform.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Ponderus Invest.